A Phase II Study of Dacomitinib in Progressive Brain Metastases
Clinical trial NCT02047747 · TERMINATED
Trial details
- NCT number
- NCT02047747
- Sponsor
- David Piccioni, M.D., Ph.D
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-01
- Primary completion
- 2016-02-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.